Dr. Julia Schaletzky, Prof. Sarah Stanley and their team at the UCB Drug Discovery center work on a repurposing approach, discovering if compounds with existing safety data in humans can be used to combat COVID-19 infection.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Julia SchaletzkyResearch Location
United States of AmericaLead Research Institution
University of California-BerkeleyResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Dr. Julia Schaletzky, Prof. Sarah Stanley and their team at the UCB Drug Discovery center work on a repurposing approach, discovering if compounds with existing safety data in humans can be used to combat COVID-19 infection.